Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 447

Similar articles for PubMed (Select 18824834)

1.

Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.

Bogan RK.

Postgrad Med. 2008 Sep;120(3):161-71. doi: 10.3810/pgm.2008.09.1916. Review.

PMID:
18824834
2.
3.

Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.

Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.

J Clin Psychiatry. 2011 Jul;72(7):914-28. doi: 10.4088/JCP.09m05571gry. Epub 2010 Dec 28.

PMID:
21208597
4.

Main neuroendocrine features and therapy in primary sleep troubles.

Amihăesei IC, Mungiu OC.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):862-6.

PMID:
23272543
5.

Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies.

Rosenberg RP.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):49-56. Review.

PMID:
16517453
7.

Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.

Walsh JK, Soubrane C, Roth T.

Am J Geriatr Psychiatry. 2008 Jan;16(1):44-57. doi: 10.1097/JGP.0b013e3181256b01.

PMID:
18165461
8.

Sleeping through the night: are extended-release formulations the answer?

Calamaro C.

J Am Acad Nurse Pract. 2008 Feb;20(2):69-75. doi: 10.1111/j.1745-7599.2007.00279.x. Review.

PMID:
18271761
9.

Extended-release zolpidem: efficacy and tolerability profile.

Owen RT.

Drugs Today (Barc). 2006 Nov;42(11):721-7. Review.

PMID:
17171191
10.

Management of chronic insomnia in elderly persons.

Bain KT.

Am J Geriatr Pharmacother. 2006 Jun;4(2):168-92. Review.

PMID:
16860264
11.

Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.

Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T.

J Clin Psychopharmacol. 2009 Jun;29(3):222-30. doi: 10.1097/JCP.0b013e3181a390ba.

PMID:
19440075
12.

Zolpidem extended-release.

Moen MD, Plosker GL.

CNS Drugs. 2006;20(5):419-26; discussion 427-8.

PMID:
16696581
13.

Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia.

Marrs JC.

Ann Pharmacother. 2008 Jul;42(7):1070-9. doi: 10.1345/aph.1K683. Epub 2008 Jul 1.

PMID:
18594049
14.

Insomnia: drug treatment.

Tsoi WF.

Ann Acad Med Singapore. 1991 Mar;20(2):269-72. Review.

PMID:
1679317
15.
16.

Management of insomnia.

Kirkwood CK.

J Am Pharm Assoc (Wash). 1999 Sep-Oct;39(5):688-96; quiz 713-4. Review.

PMID:
10533351
17.

Zolpidem: a review of its use in the management of insomnia.

Swainston Harrison T, Keating GM.

CNS Drugs. 2005;19(1):65-89. Review.

PMID:
15651908
18.

Zaleplon: a review of its use in the treatment of insomnia.

Dooley M, Plosker GL.

Drugs. 2000 Aug;60(2):413-45. Review.

PMID:
10983740
19.

Melatonin agonists in primary insomnia and depression-associated insomnia: are they superior to sedative-hypnotics?

Srinivasan V, Brzezinski A, Pandi-Perumal SR, Spence DW, Cardinali DP, Brown GM.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):913-23. doi: 10.1016/j.pnpbp.2011.03.013. Epub 2011 Mar 29. Review.

PMID:
21453740
20.

Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.

Hoehns JD, Perry PJ.

Clin Pharm. 1993 Nov;12(11):814-28. Review. Erratum in: Clin Pharm 1993 Dec;12(12):881.

PMID:
8275648
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk